The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Sino Biopharm included in Pharm Exec 50 for six years running
Sino Biopharmaceutical Limited, or Sino Biopharm, has been selected on the list of the top 50 global pharmaceutical companies (Pharm Exec 50), making it on this list for the sixth consecutive year.
June18,2024
Chinese pharma to develop global ESG strategy, promote health equity worldwide
Chinese biotechnology company BeiGene recently released its 2021 report on environmental, social and governance (ESG), proposing a "change is the cure" strategy that focuses on advancing global health, empowering employees, sustainable innovation, supporting communities and operating responsibly, reported China Securities Journal on Tuesday.
June07,2022
Chinese sci-tech information provider PatSnap launches database on global new drugs
Chinese sci-tech innovation information provider PatSnap on Wednesday launched a database focusing on tracking global new drug updates, providing information services for research and development (R&D) decision-makers of pharmaceutical enterprises, industrial researchers and investors, reported the Xinhua-run China Securities Journal.
March31,2022
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
